1. Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
   Chun Chau Lawrence Cheung et al, 2023, Frontiers in Immunology CrossRef
2. Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
   Yang Li et al, 2021, Frontiers in Bioengineering and Biotechnology CrossRef
3. Immune escape mechanism behind resistance to anti-PD-1 therapy in gastrointestinal tract metastasis in malignant melanoma patients with multiple metastases
   Misato Ito et al, 2022, Cancer Immunology, Immunotherapy CrossRef
4. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer
   Aung Kyi Thar Min et al, 2021, Cancer Immunology, Immunotherapy CrossRef
5. Integrated analysis from multi-center studies identities m7G-derived modification pattern and risk stratification system in skin cutaneous melanoma
   Xin Zhang et al, 2022, Frontiers in Immunology CrossRef
6. Expression Patterns of Immune Checkpoints in Breast Cancer Patients
   Ruirui Ma et al, 2023, Academic Journal of Science and Technology CrossRef
7. Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update
   Yannick Verhoeven et al, 2021, International Journal of Molecular Sciences CrossRef
8. Development of Exhausted Memory Monocytes and Underlying Mechanisms
   Kisha Pradhan et al, 2021, Frontiers in Immunology CrossRef
9. Transcription Factors in Cancer
   Rawiah A. Alsiary et al, 2023, Molecular Targets and Cancer Therapeutics (Part 1) CrossRef
10. Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma
    Benjamin Sundqvist et al, 2022, Cancers CrossRef
11. Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer
    Yuko Nakayama et al, 2020, Gastric Cancer CrossRef
12. The association between PI3K , JAK / STAT pathways with the PDL ‐1 expression in prostate cancer
    Ozgur Kazan et al, 2022, Andrologia CrossRef
13. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
    Zihao Chen et al, 2021, Frontiers in Immunology CrossRef
14. Blood glutamate scavengers increase pro-apoptotic signaling and reduce metastatic melanoma growth in-vivo
    Yona Goldshmit et al, 2021, Scientific Reports CrossRef
15. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma
    Manel Benhassine et al, 2022, International Journal of Molecular Sciences CrossRef
16. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target
    Haizhou Wang et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
17. What role does PDL1 play in EMT changes in tumors and fibrosis?
    Yun-Chao Zhang et al, 2023, Frontiers in Immunology CrossRef